ORDER A TEST Log In Contact Us
image description
CARE PATHWAY intelligence SOLUTION

Tempus Next

An AI-enabled care pathway platform that enables providers to deliver the Next step in a patient’s care journey.

LEARN MORE LOG IN

Improve adherence to clinical guidelines through AI-enabled, accurate and targeted notifications at the point of care.

image description image description

Upcoming webinar

Using AI to identify and close gaps in care for cancer patients

Learn how TriHealth Cancer and Blood Institute implemented Tempus Next to accelerate the adoption of precision care pathways for NSCLC patients.

Register now

Our Solution

Tempus Next: AI-enabled care pathway intelligence

Tempus Next applies technology, data, and AI to enable precision medicine, empowering providers to deliver the next step in a patient’s care journey and foster value based care within health systems.

Identify and contextualize patients in their care journey

AI-enabled solutions surface deep insights from multimodal, longitudinal patient data including medical imaging data, EHR data, lab results, pathology reports and clinician notes.

image description

Surface precision care pathways at the point of care

Tiered and customized notifications consistent with precision medicine guidelines in the physician’s workflow reduce alert fatigue.

image description

Track patients for timely follow-up to help improve outcomes

Patient Tracking for patients with current disease who need management, Patient Lists to search for subsets of patients and Dashboards to track insights into a hospital’s patient population.

image description

Monitor notification effectiveness and guidelines adoption

Institution-level insights reports delivered to hospital systems help understand effectiveness of the notifications, emerging trends in guideline adoption, and patient outcomes.

image description

Increase equitable access to precision care

Timely and accurate diagnostics, procedures and therapies for all patients, regardless of socioeconomic status.

Figure: Average time from index echo to follow-up for black and white patients, showing the improvement in black patients’ time to follow up towards the average seen in white patients’ (narrowing the gap).

image description
Don’t take our word for it, here’s how others are using Tempus Next:

Ensuring all patients have access to biomarker testing and personalized therapy aligns with our mission at TriHealth to improve the health status of the people we serve. Our partnership with Tempus on the Next program supports our quality measures and helped to identify opportunities for efficient and seamless precision oncology care. The integration of Tempus Next into our existing systems at TriHealth makes it a valuable tool for our clinicians, enhancing patient care without adding to their workload.

Karen Huelsman, MS, LGC, Precision Oncology Lead and Licensed Genetic Counselor

Don’t take our word for it, here’s how others are using Tempus Next:

The reason Tempus Next is a game changer in patient care is that it can pick up data points from both discrete and non-discrete data in the EHR to identify patients who have valvular heart disease but no current treatment plan. Its ability to synthesize complex data points into actionable insights ensures that patients receive the care they need, precisely when they need it, according to the latest guidelines.

Dr. Daniel O'Hair, Medical Director, Cardiovascular Serviceline, Boulder Community Health

Case Study

Closing the biomarker testing gap for early stage NSCLC patients with Tempus Next

Learn how Tempus Next was deployed at TriHealth Cancer and Blood Institute in Cincinnati, Ohio to surface and close gaps in biomarker testing for NSCLC patients.

LEARN MORE
image description

Case Study

Identifying patients with Valvular Heart Disease: A partnership between a specialty designated cardiac center and Tempus

Learn how the deployment of Tempus Next, an AI-enabled clinical care pathway solution, at a specialty designated cardiac and heart valve center helped enable guideline directed care for patients with structural heart disease.

LEARN MORE
image description

Learn more about Tempus Next

Chris Scotto DiVetta, SVP of Applications at Tempus AI introduces Tempus Next, an AI enabled care pathway platform that helps providers accelerate the adoption of evidence based care.

Watch replay
  • NEXT for Oncology

    Reduce undertesting of biomarkers associated with immunotherapy eligibility  (PDL1, MSI, TMB)

    Identify patients with actionable alterations to consider for FDA approved targeted therapies consistent with clinical guidelines

    Help prevent chemotherapy toxicity in patients with identifiable pharmacogenomic alterations

  • NEXT for CARDIOLOGY

    60+ care pathway management algorithms in cardiovascular disease

    Increase timely guideline driven referrals for diagnostics and subspecialists

    Highly experienced integration team with streamlined processes

Reduce undertesting of biomarkers associated with immunotherapy eligibility  (PDL1, MSI, TMB)

Identify patients with actionable alterations to consider for FDA approved targeted therapies consistent with clinical guidelines

Help prevent chemotherapy toxicity in patients with identifiable pharmacogenomic alterations

60+ care pathway management algorithms in cardiovascular disease

Increase timely guideline driven referrals for diagnostics and subspecialists

Highly experienced integration team with streamlined processes

Learn more

This is data-driven precision medicine

This is the future of healthcare.